Novelion Therapeutics Inc (NVLN) Return on Assets ROA from the first quarter of 2019 to first quarter of 2018 and for the year 2019, Average High and Low, Fundamental Ratios from Mar 31 2019 to Mar 31 2018 - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Novelion Therapeutics Inc   (NVLN)


Novelion Therapeutics Inc 's ROA from the first quarter of 2019 to the first quarter of 2018 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Novelion Therapeutics Inc 's ROA in the first quarter of 2019?
Novelion Therapeutics Inc recorded a cumulative net loss of $-107 million during 12 months ending in the first quarter of 2019, resulting in a negative return on assets (ROA) of -31.83%.

However, within the Healthcare sector 398 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Mar 31 2019 quarter, so far to 4143, from total ROA ranking in the fourth quarter of 2018 at 4575.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Mar 31 2019)
I. Quarter		 (Dec 31 2018)
IV. Quarter		 (Sep 30 2018)
III. Quarter		 (Jun 30 2018)
II. Quarter		 (Mar 31 2018)
I. Quarter
Y / Y Total Assets Change -4.56 % -7.48 % -20.41 % -22.7 % -19.83 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -107 -108 -113 -138 -129
Return On Assets (TTM) -31.83 % -31.73 % -32.58 % -37.5 % -32.63 %
NVLN's Total Ranking # 4143 # 4575 # 4101 # 3806 # 3775
Total Assets (TTM) in million 342 342 325 340 358
Seq. Total Assets Change 0.12 % 5.15 % -4.51 % -5.06 % -2.94 %
Seq. Net Income Change - - - - -

NVLN's 5 Years Annual ROA >> Back to NVLN Management Effectiveness >> Compare NVLN ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 163
Sector # 399
Overall # 3954

Return On Assets Statistics
High Average Low
-9.57 %
-21.71 %
-32.58 %
(Dec 31 2017)   (Sep 30 2018)





Financial Statements
Novelion Therapeutics Inc 's Assets $ 342 million NVLN's Balance sheet
Novelion Therapeutics Inc 's Income $ -32 million Quarterly NVLN's Income Statement
NVLN's Income by Division See NVLN's Income by Division



Annual Return On Assets (Dec 31 2018)
FY 2018		 (Dec 31 2017)
FY 2017		 (Dec 31 2016)
FY 2016
FY
FY
Y / Y Total Assets Change -7.48 % -23.16 % - - -
Total Assets in million 342 369 481 0 0
Y / Y Net Income Change - - - - -
Net Income in million -108 -127 -53 0 0
Annual Return On Assets -31.7 % -34.31 % -11 % - -

NVLN's 5 Years Annual ROA >> Back to NVLN Management Effectiveness >> Compare NVLN ROA to its Competitors



More Return On Assets Ratios
NVLN's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
NVLN's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for NVLN's Competitors
Subscribers only: Roa for Novelion Therapeutics Inc 's Suppliers
Subscribers only: Return On Assets for NVLN's Customers

You may also want to know
NVLN's Roi NVLN's Inventory Turnover Ratio NVLN's Growth Rates NVLN's Dividend Comparisons
NVLN's Profitability Ratios NVLN's Asset Turnover Ratio NVLN's Dividend Growth
NVLN's Roe NVLN's Valuation Ratios NVLN's Financial Strength Ratios NVLN's Dividend Payout Ratio



Companies with similar Return On Assets at Mar 31 2019, within Healthcare Sector ROA

Date modified: 2026-09-08T15:09:34+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.